Clinical trials for coronavirus disease 2019: What is being evaluated and what is not

Yaseen M Arabi¹, Ayed Asseri², Steve Webb³, John Marshall⁴, Mohamed S Al Moamary^5
1 Intensive Care Department, Ministry of National Guard Health Affairs; King Abdullah International Medical Research Center; Intensive Care Department, College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
² Intensive Care Department, Prince Mohammed Bin Abdulaziz Hospital - Ministry of Health, Riyadh, Saudi Arabia
³ Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
⁴ Interdepartmental Division of Critical Care Medicine, Keenan Research Centre for Biomedical Science, St. Michael's Hospital, University of Toronto, Toronto, Canada
⁵ College of Medicine, King Saud Bin Abdulaziz University for Health Sciences; Department of Medicine, King Abdulaziz Medical City, Riyadh, Saudi Arabia

Correspondence Address:
Prof. Yaseen M Arabi
Intensive Care Department, Respiratory Services, College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, P.O. Box 22490 Riyadh 11426
Saudi Arabia

Source of Support: None, Conflict of Interest: None

Check

DOI: 10.4103/atm.ATM_99_20